Turn Therapeutics Inc. Issues Press Release Under Regulation FD

What Happened Turn Therapeutics Inc. (TTRX) filed a Current Report on Form 8‑K on September 10, 2026 to disclose a company press release under Item 7.01 (Regulation FD Disclosure). The press release is furnished as Exhibit 99.1 to the 8‑K. The filing also includes the cover page interactive XBRL file under Item 9.01.

Key Details

• Filing date: September 10, 2026 (Form 8‑K, Items 7.01 and 9.01).
• Exhibit provided: Press Release dated September 10, 2026 (Exhibit 99.1).
• Interactive XBRL cover page included (Exhibit 104).
• This filing does not report earnings results, executive changes, mergers/acquisitions, or financial statements.

Why It Matters A Regulation FD disclosure means Turn publicly released information that could be material to investors; the 8‑K simply furnishes that press release to the SEC. Investors should review Exhibit 99.1 (the press release) or the company’s website/EDGAR filing to determine whether the released information affects the company’s outlook, operations, or valuation.